Mutant proteins as cancer-specific biomarkers.
Cancer biomarkers are currently the subject of intense research because of their potential utility for diagnosis, prognosis, and targeted therapy. In theory, the gene products resulting from somatic mutations are the ultimate protein biomarkers, being not simply associated with tumors but actually responsible for tumorigenesis. We show here that the altered protein products resulting from somatic mutations can be identified directly and quantified by mass spectrometry. The peptides expressed from normal and mutant alleles were detected by selected reaction monitoring (SRM) of their product ions using a triple-quadrupole mass spectrometer. As a prototypical example of this approach, we demonstrated that it is possible to quantify the number and fraction of mutant Ras protein present in cancer cell lines. There were an average of 1.3 million molecules of Ras protein per cell, and the ratio of mutant to normal Ras proteins ranged from 0.49 to 5.6. Similarly, we found that mutant Ras proteins could be detected and quantified in clinical specimens such as colorectal and pancreatic tumor tissues as well as in premalignant pancreatic cyst fluids. In addition to answering basic questions about the relative levels of genetically abnormal proteins in tumors, this approach could prove useful for diagnostic applications.
Ludwig Center for Cancer Genetics and Therapeutics and The Howard Hughes Medical Institute, Johns Hopkins Kimmel Cancer Center, Baltimore, MD21231, USA.
Qing
Q
Wang
Raghothama
R
Chaerkady
Jian
J
Wu
Hee Jung
HJ
Hwang
Nick
N
Papadopoulos
Levy
L
Kopelovich
Anirban
A
Maitra
Hanno
H
Matthaei
James R
JR
Eshleman
Ralph H
RH
Hruban
Kenneth W
KW
Kinzler
Akhilesh
A
Pandey
Bert
B
Vogelstein
D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism*; D045744:Cell Line, Tumor; D005260:Female; D006801:Humans; D008297:Male; D050505:Mutant Proteins / Q000235:genetics / Q000378:metabolism*; D009363:Neoplasm Proteins / Q000235:genetics / Q000378:metabolism*; D009369:Neoplasms / Q000235:genetics / Q000378:metabolism*; D018631:ras Proteins / Q000235:genetics / Q000378:metabolism*
D014408:Biomarkers, Tumor; D050505:Mutant Proteins; D009363:Neoplasm Proteins; D018631:ras Proteins
Proteomics. 2008 May;8(9):1898-908
18442173
Amyloid. 2004 Mar;11(1):61-6
15185501
Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18132-8
18818311
Anal Chem. 2002 Feb 15;74(4):741-51
11866053
J Mass Spectrom. 1996 Nov;31(11):1203-15
8946729
Nat Biotechnol. 2009 Jul;27(7):633-41
19561596
Proteomics. 2007 Feb;7(3):340-50
17177251
J Proteome Res. 2010 Oct 1;9(10):4982-91
20677825
J Proteome Res. 2004 Mar-Apr;3(2):235-44
15113099
Mol Cell Proteomics. 2002 May;1(5):376-86
12118079
Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18545-50
20876136
Science. 2007 Nov 16;318(5853):1108-13
17932254
Nature. 1983 Aug 11-17;304(5926):507-13
6308467
Clin Gastroenterol Hepatol. 2008 Nov;6(11):1194-7
18848907
Anal Biochem. 2007 Mar 1;362(1):44-54
17241609
Amyloid. 2007 Mar;14(1):65-71
17453626
J Proteome Res. 2007 Jun;6(6):2331-40
17488105
Science. 2008 Sep 26;321(5897):1807-12
18772396
Nat Med. 1997 Dec;3(12):1413-6
9396615
Clin Chem. 2004 Sep;50(9):1535-43
15205369
Electrophoresis. 1996 May;17(5):945-53
8783021
Mol Cell Proteomics. 2006 Apr;5(4):573-88
16332733
J Mass Spectrom. 2003 Apr;38(4):357-72
12717747
Gastrointest Endosc. 2009 May;69(6):1103-5
19410042
Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):6940-5
12771378
Mol Cell Proteomics. 2005 Oct;4(10):1487-502
15979981
J Proteome Res. 2010 Feb 5;9(2):761-76
19921851
Nature. 2009 Apr 9;458(7239):719-24
19360079
Nature. 2010 Feb 18;463(7283):893-8
20164919
Bioinformatics. 2010 Apr 1;26(7):966-8
20147306
J Clin Microbiol. 2002 May;40(5):1575-80
11980924
Nat Methods. 2010 Jan;7(1):43-6
19966807
Nature. 2002 Aug 29;418(6901):934
12198537
Clin Transl Oncol. 2006 Aug;8(8):566-80
16952845
Cancer J Sci Am. 1998 May-Jun;4(3):194-203
9612602
J Proteome Res. 2008 Mar;7(3):1118-30
18271523
Science. 2008 Sep 26;321(5897):1801-6
18772397